FAM72A degrades UNG2 through the GID/CTLH complex to promote mutagenic repair during antibody maturation

FAM72A通过GID/CTLH复合物降解UNG2,从而促进抗体成熟过程中的突变修复。

阅读:2
作者:Philip Barbulescu # ,Chetan K Chana # ,Matthew K Wong ,Ines Ben Makhlouf ,Jeffrey P Bruce ,Yuqing Feng ,Alexander F A Keszei ,Cassandra Wong ,Rukshana Mohamad-Ramshan ,Laura C McGary ,Mohammad A Kashem ,Derek F Ceccarelli ,Stephen Orlicky ,Yifei Fang ,Huihui Kuang ,Mohammad Mazhab-Jafari ,Rossanna C Pezo ,Ashok S Bhagwat ,Trevor J Pugh ,Anne-Claude Gingras ,Frank Sicheri ,Alberto Martin

Abstract

A diverse antibody repertoire is essential for humoral immunity. Antibody diversification requires the introduction of deoxyuridine (dU) mutations within immunoglobulin genes to initiate somatic hypermutation (SHM) and class switch recombination (CSR). dUs are normally recognized and excised by the base excision repair (BER) protein uracil-DNA glycosylase 2 (UNG2). However, FAM72A downregulates UNG2 permitting dUs to persist and trigger SHM and CSR. How FAM72A promotes UNG2 degradation is unknown. Here, we show that FAM72A recruits a C-terminal to LisH (CTLH) E3 ligase complex to target UNG2 for proteasomal degradation. Deficiency in CTLH complex components result in elevated UNG2 and reduced SHM and CSR. Cryo-EM structural analysis reveals FAM72A directly binds to MKLN1 within the CTLH complex to recruit and ubiquitinate UNG2. Our study further suggests that FAM72A hijacks the CTLH complex to promote mutagenesis in cancer. These findings show that FAM72A is an E3 ligase substrate adaptor critical for humoral immunity and cancer development.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。